Skip to main content
Top
Published in: International Journal of Hematology 1/2010

01-07-2010 | Original Article

Late effects and quality of life of childhood cancer survivors: Part 2. Impact of radiotherapy

Authors: Yasushi Ishida, Naoko Sakamoto, Kiyoko Kamibeppu, Naoko Kakee, Tsuyako Iwai, Shuichi Ozono, Naoko Maeda, Jun Okamura, Keiko Asami, Hiroko Inada, Misato Honda, Keizo Horibe

Published in: International Journal of Hematology | Issue 1/2010

Login to get access

Abstract

To examine the late effects and health-related quality of life of childhood cancer survivors (CCS) after radiotherapy (RT), we performed a cross-sectional survey using self-rating questionnaires. The subjects were divided into 3 groups: CCS treated with or without RT, and a general population matched for age, gender, residential area, and work status. The numbers in each group were 113, 72, and 1,000, respectively. The median ages of CCS at diagnosis and the time of the survey were 8 and 22 years, respectively. The mean final heights of males and females were significantly lower in CCS with RT than in the other 2 groups. Risk factors for a short stature were total body irradiation (TBI) [odds ratio (OR) 17.8, p < 0.001], spinal irradiation (OR 8.31, p = 0.033), and an age younger than 10 years at diagnosis. Late effects were observed in 68% of CCS with RT compared with 36% of CCS without RT. Multivariate analysis revealed that TBI was significantly associated with endocrine dysfunction (OR 12.3), skull and spinal irradiation with cognitive dysfunction (OR 16.1 and 11.5, respectively), and spinal irradiation with a short stature (OR 14.1), respectively. Physical dysfunction, psychological stress, and problems of social adaptation were observed in >50% of CCS with RT.
Literature
1.
go back to reference Robison LL, Armstrong GT, Boice JD, Chow EJ, Davies SM, Donaldson SS, et al. The Childhood Cancer Survivor Study: a National Cancer Institute-supported resource for outcome and intervention research. J Clin Oncol. 2009;27(14):2308–18. doi:10.1200/JCO.2009.22.3339.CrossRefPubMed Robison LL, Armstrong GT, Boice JD, Chow EJ, Davies SM, Donaldson SS, et al. The Childhood Cancer Survivor Study: a National Cancer Institute-supported resource for outcome and intervention research. J Clin Oncol. 2009;27(14):2308–18. doi:10.​1200/​JCO.​2009.​22.​3339.CrossRefPubMed
2.
go back to reference Hawkins MM, Lancashire ER, Winter DL, Frobisher C, Reulen RC, Taylor AJ, et al. The British Childhood Cancer Survivor Study: objectives, methods, population structure, response rates and initial descriptive information. Pediatr Blood Cancer. 2008;50(5):1018–25. doi:10.1002/pbc.21335.CrossRefPubMed Hawkins MM, Lancashire ER, Winter DL, Frobisher C, Reulen RC, Taylor AJ, et al. The British Childhood Cancer Survivor Study: objectives, methods, population structure, response rates and initial descriptive information. Pediatr Blood Cancer. 2008;50(5):1018–25. doi:10.​1002/​pbc.​21335.CrossRefPubMed
3.
go back to reference Geenen MM, Cardous-Ubbink MC, Kremer LC, van den Bos C, van der Pal HJ, Heinen RC, et al. Medical assessment of adverse health outcomes in long-term survivors of childhood cancer. JAMA. 2007;297(24):2705–15. Geenen MM, Cardous-Ubbink MC, Kremer LC, van den Bos C, van der Pal HJ, Heinen RC, et al. Medical assessment of adverse health outcomes in long-term survivors of childhood cancer. JAMA. 2007;297(24):2705–15.
4.
5.
go back to reference Ishida Y, Honda M, Ozono S, Okamura J, Asami K, Maeda N, et al. Late effects and quality of life of childhood cancer survivors: Part 1 Impact of the stem cell transplantation. Int J Hematol. 2010. doi:10.1007/s12185-010-0584-y. Ishida Y, Honda M, Ozono S, Okamura J, Asami K, Maeda N, et al. Late effects and quality of life of childhood cancer survivors: Part 1 Impact of the stem cell transplantation. Int J Hematol. 2010. doi:10.​1007/​s12185-010-0584-y.
6.
go back to reference Green DM, Sklar CA, Boice JD Jr, Mulvihill JJ, Whitton JA, Stovall M, et al. Ovarian failure and reproductive outcomes after childhood cancer treatment: results from the Childhood Cancer Survivor Study. J Clin Oncol. 2009;27(14):2374–81. doi:10.1200/JCO.2008.21.1839.CrossRefPubMed Green DM, Sklar CA, Boice JD Jr, Mulvihill JJ, Whitton JA, Stovall M, et al. Ovarian failure and reproductive outcomes after childhood cancer treatment: results from the Childhood Cancer Survivor Study. J Clin Oncol. 2009;27(14):2374–81. doi:10.​1200/​JCO.​2008.​21.​1839.CrossRefPubMed
7.
go back to reference Hudson MM, Mulrooney DA, Bowers DC, Sklar CA, Green DM, Donaldson SS, et al. High-risk populations identified in Childhood Cancer Survivor Study investigations: implications for risk-based surveillance. J Clin Oncol. 2009;27(14):2405–14. doi:10.1200/JCO.2008.21.1516.CrossRefPubMed Hudson MM, Mulrooney DA, Bowers DC, Sklar CA, Green DM, Donaldson SS, et al. High-risk populations identified in Childhood Cancer Survivor Study investigations: implications for risk-based surveillance. J Clin Oncol. 2009;27(14):2405–14. doi:10.​1200/​JCO.​2008.​21.​1516.CrossRefPubMed
8.
go back to reference Meadows AT, Friedman DL, Neglia JP, Mertens AC, Donaldson SS, Stovall M, et al. Second neoplasms in survivors of childhood cancer: findings from the Childhood Cancer Survivor Study cohort. J Clin Oncol. 2009;27(14):2356–62. doi:10.1200/JCO.2008.21.1920.CrossRefPubMed Meadows AT, Friedman DL, Neglia JP, Mertens AC, Donaldson SS, Stovall M, et al. Second neoplasms in survivors of childhood cancer: findings from the Childhood Cancer Survivor Study cohort. J Clin Oncol. 2009;27(14):2356–62. doi:10.​1200/​JCO.​2008.​21.​1920.CrossRefPubMed
11.
go back to reference Ishiguro H, Yasuda Y, Tomita Y, Shinagawa T, Shimizu T, Morimoto T, et al. Long-term follow-up of thyroid function in patients who received bone marrow transplantation during childhood and adolescence. J Clin Endocrinol Metab. 2004;89(12):5981–6. Ishiguro H, Yasuda Y, Tomita Y, Shinagawa T, Shimizu T, Morimoto T, et al. Long-term follow-up of thyroid function in patients who received bone marrow transplantation during childhood and adolescence. J Clin Endocrinol Metab. 2004;89(12):5981–6.
12.
go back to reference Ishida Y, Honda M, Kamibeppu K, Ozono S, Iwai T, Kakee N, et al. Cross-sectional survey on the late effects and QOL of childhood cancer survivors, Part 1. J Jpn Pediatr Soc. 2010;114(4):665–75. Ishida Y, Honda M, Kamibeppu K, Ozono S, Iwai T, Kakee N, et al. Cross-sectional survey on the late effects and QOL of childhood cancer survivors, Part 1. J Jpn Pediatr Soc. 2010;114(4):665–75.
13.
go back to reference Gurney JG, Ness KK, Stovall M, Wolden S, Punyko JA, Neglia JP, et al. Final height and body mass index among adult survivors of childhood brain cancer: childhood cancer survivor study. J Clin Endocrinol Metab. 2003;88(10):4731–9. Gurney JG, Ness KK, Stovall M, Wolden S, Punyko JA, Neglia JP, et al. Final height and body mass index among adult survivors of childhood brain cancer: childhood cancer survivor study. J Clin Endocrinol Metab. 2003;88(10):4731–9.
14.
go back to reference Chow EJ, Friedman DL, Yasui Y, Whitton JA, Stovall M, Robison LL, et al. Decreased adult height in survivors of childhood acute lymphoblastic leukemia: a report from the Childhood Cancer Survivor Study. J Pediatr. 2007;150(4):370–5, 375.e1. doi:10.1016/j.jpeds.2006.11.036. Chow EJ, Friedman DL, Yasui Y, Whitton JA, Stovall M, Robison LL, et al. Decreased adult height in survivors of childhood acute lymphoblastic leukemia: a report from the Childhood Cancer Survivor Study. J Pediatr. 2007;150(4):370–5, 375.e1. doi:10.​1016/​j.​jpeds.​2006.​11.​036.
16.
17.
go back to reference Nandagopal R, Laverdiere C, Mulrooney D, Hudson MM, Meacham L. Endocrine late effects of childhood cancer therapy: a report from the Children’s Oncology Group. Horm Res. 2008;69(2):65–74. doi:10.1159/000111809.CrossRefPubMed Nandagopal R, Laverdiere C, Mulrooney D, Hudson MM, Meacham L. Endocrine late effects of childhood cancer therapy: a report from the Children’s Oncology Group. Horm Res. 2008;69(2):65–74. doi:10.​1159/​000111809.CrossRefPubMed
18.
go back to reference Chemaitilly W, Boulad F, Sklar C. Endocrine complications of childhood hematopoietic stem-cell transplantation. In: Kline R, editor. Pediatric hematopoietic stem cell transplantation. New York: Informa Healthcare USA; 2006. p. 287–398. Chemaitilly W, Boulad F, Sklar C. Endocrine complications of childhood hematopoietic stem-cell transplantation. In: Kline R, editor. Pediatric hematopoietic stem cell transplantation. New York: Informa Healthcare USA; 2006. p. 287–398.
20.
go back to reference Sanders JE. Endocrine complications of high-dose therapy with stem cell transplantation. Pediatr Transplant. 2004;8(Suppl 5):39–50. Sanders JE. Endocrine complications of high-dose therapy with stem cell transplantation. Pediatr Transplant. 2004;8(Suppl 5):39–50.
22.
go back to reference Brownstein CM, Mertens AC, Mitby PA, Stovall M, Qin J, Heller G, et al. Factors that affect final height and change in height standard deviation scores in survivors of childhood cancer treated with growth hormone: a report from the childhood cancer survivor study. J Clin Endocrinol Metab. 2004;89(9):4422–7. Brownstein CM, Mertens AC, Mitby PA, Stovall M, Qin J, Heller G, et al. Factors that affect final height and change in height standard deviation scores in survivors of childhood cancer treated with growth hormone: a report from the childhood cancer survivor study. J Clin Endocrinol Metab. 2004;89(9):4422–7.
23.
go back to reference Larson DL, Kroll S, Jaffe N, Serure A, Goepfert H. Long-term effects of radiotherapy in childhood and adolescence. Am J Surg. 1990;160(4):348–51. Larson DL, Kroll S, Jaffe N, Serure A, Goepfert H. Long-term effects of radiotherapy in childhood and adolescence. Am J Surg. 1990;160(4):348–51.
24.
25.
go back to reference Neglia JP, Friedman DL, Yasui Y, Mertens AC, Hammond S, Stovall M, et al. Second malignant neoplasms in five-year survivors of childhood cancer: childhood cancer survivor study. J Natl Cancer Inst. 2001;93(8):618–29. Neglia JP, Friedman DL, Yasui Y, Mertens AC, Hammond S, Stovall M, et al. Second malignant neoplasms in five-year survivors of childhood cancer: childhood cancer survivor study. J Natl Cancer Inst. 2001;93(8):618–29.
26.
go back to reference Han JW, Kwon SY, Won SC, Shin YJ, Ko JH, Lyu CJ. Comprehensive clinical follow-up of late effects in childhood cancer survivors shows the need for early and well-timed intervention. Ann Oncol. 2009;20(7):1170–7. doi:10.1093/annonc/mdn778.CrossRefPubMed Han JW, Kwon SY, Won SC, Shin YJ, Ko JH, Lyu CJ. Comprehensive clinical follow-up of late effects in childhood cancer survivors shows the need for early and well-timed intervention. Ann Oncol. 2009;20(7):1170–7. doi:10.​1093/​annonc/​mdn778.CrossRefPubMed
Metadata
Title
Late effects and quality of life of childhood cancer survivors: Part 2. Impact of radiotherapy
Authors
Yasushi Ishida
Naoko Sakamoto
Kiyoko Kamibeppu
Naoko Kakee
Tsuyako Iwai
Shuichi Ozono
Naoko Maeda
Jun Okamura
Keiko Asami
Hiroko Inada
Misato Honda
Keizo Horibe
Publication date
01-07-2010
Publisher
Springer Japan
Published in
International Journal of Hematology / Issue 1/2010
Print ISSN: 0925-5710
Electronic ISSN: 1865-3774
DOI
https://doi.org/10.1007/s12185-010-0611-z

Other articles of this Issue 1/2010

International Journal of Hematology 1/2010 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine